January 16, 2020 Articles

The Top Five Drug and Device Developments of 2019

A “negotiation class,” plaintiffs’ legal ads, vaping, multidistrict litigation reform, and Daubert gatekeeping.

By Hannah Anderson, Isabelle Chammas, Christine Kain, and Patrick Reilly

As we prepare to welcome both a new year and a new decade, we look back on the developments in drug and device law this year and potential implications for 2020. Below is a brief recap and assessment of the top five developments from 2019.

Premium Content For:
  • Litigation Section
Join - Now